Literature DB >> 35116719

Aggressive sebaceous carcinoma of the scalp: a case report and literature review.

Guihong Li1, Jing Shen2, Haiyan Huang3, Ruili Chen4, Guangtong Zhou1.   

Abstract

Sebaceous carcinoma (SC) is an uncommon and potentially aggressive adnexal neoplasm. SC presents most often as a periocular tumor arising from the ocular adnexa with unclear pathogenesis. Aggressive SC of the scalp is extremely rare. Here, we describe a rare case of aggressive SC of the scalp in a 61-year-old female, who presented with a scalp neoplasm lasting for two months. Cranial magnetic resonance imaging (MRI) revealed a partly necrotic and cystic tumor with mixed signal shadow. The parietal multiple destructive lesions invaded the skull, involved the dura mater, and compressed the associated superior sagittal sinus. A wide local lesion excision with I stage repair of dura mater and I stage bone graft of skull was performed in our department. The patient was treated with external radiation to prevent recurrence and was followed for 3 years with favorable results. The relevant literature regarding aggressive SC was reviewed, and the clinical manifestations, radiological characteristics, surgical strategies, histopathological findings, and prognosis are discussed. This cutaneous malignancy invaded skull, dura mater or brain, or metastasized to the lymph nodes and viscera, with high recurrence and fatality rates. It is necessary to be aware of these rare examples which showed unexpectedly clinical behaviors. Early precise diagnosis and improved radical treatment remain essential steps against aggressive cutaneous malignancy. Patients with aggressive SC of the scalp should be closely followed to assess recurrence and distant metastasis. 2021 Translational Cancer Research. All rights reserved.

Entities:  

Keywords:  Scalp; aggressive; case report; sebaceous carcinoma (SC)

Year:  2021        PMID: 35116719      PMCID: PMC8798961          DOI: 10.21037/tcr-20-3443

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN: 2218-676X            Impact factor:   1.241


Introduction

Sebaceous carcinoma (SC) is a rare and potentially aggressive adnexal neoplasm that was first described by Straatsma in 1956 (1). SC most commonly presents as a periocular tumor arising from the ocular adnexa (2). Extraocular SC is considered as a less aggressive neoplasm and occurs most commonly on the neck and scalp (3). The pathogenesis of SC is poorly understood. However, Muir-Torre syndrome (MTS), a genetic disease associated with visceral neoplasms is significantly associated with it (4). Aggressive SC of the scalp is extremely rare, and only five previous cases having been found in the literature (5-9). These cutaneous malignancies invaded skull, dura mater, brain, or metastasized to the lymph nodes and viscera, with high recurrence and fatality rates. Herein, an aggressive SC of the scalp is presented that involved dura mater, and the clinical profiles from relevant literature are summarized. We present the following article in accordance with the CARE reporting checklist (available at https://dx.doi.org/10.21037/tcr-20-3443).

Case presentation

A 61-year-old female was admitted to The First Hospital of Jilin University (Changchun, Jilin, China), after presenting with a scalp neoplasm lasting for two months. Physical examination revealed a 6 cm mass across the parietal region of her scalp, which was oval, markedly tender, without pus rupture, and fixed to the skull. There was no neurological deficit or swollen lymph node. There was no other neoplasm presented in the patient or her family. Computed tomography (CT) showed a mixed density shadow, approximately 7.5 cm × 4 cm, in the subcutaneous soft tissue of the bilateral parietal (). The CT in the bone window showed that the parietal bone was discontinuous and the density was significantly uneven (). Cranial magnetic resonance imaging (MRI) revealed a partly necrotic and cystic tumor with mixed signal shadow in T2WI. The parietal multiple destructive lesions invaded the skull, involved the dura mater, and compressed the associated superior sagittal sinus (). The patient was diagnosed with a subcutaneous mass that tended to be malignant.
Figure 1

Preoperative examination and postoperative CT. (A) CT of head showed a mixed density shadow in the subcutaneous soft tissue of the bilateral parietal; (B) bone window CT showed that the parietal bone density was significantly uneven with bone discontinuity; (C,D,E) cranial MRI revealed a partly necrotic and cystic tumor with mixed signal shadow in T2WI. The parietal multiple destructive lesions Invaded the skull, involving the dura mater, and compressed the associated superior sagittal sinus. (C) axial T2WI; (D) sagittal T2WI; (E) coronal T2WI; (F) postoperative CT confirmed that the tumor was completely removed, and the skull was repaired with the titanium plate bone graft. CT, computed tomography; MRI, magnetic resonance imaging.

Preoperative examination and postoperative CT. (A) CT of head showed a mixed density shadow in the subcutaneous soft tissue of the bilateral parietal; (B) bone window CT showed that the parietal bone density was significantly uneven with bone discontinuity; (C,D,E) cranial MRI revealed a partly necrotic and cystic tumor with mixed signal shadow in T2WI. The parietal multiple destructive lesions Invaded the skull, involving the dura mater, and compressed the associated superior sagittal sinus. (C) axial T2WI; (D) sagittal T2WI; (E) coronal T2WI; (F) postoperative CT confirmed that the tumor was completely removed, and the skull was repaired with the titanium plate bone graft. CT, computed tomography; MRI, magnetic resonance imaging. A wide local lesion excision with I stage repair of dura mater and I stage bone graft of skull was performed in our department. The scalp was cut along the anterior and posterior side of the tumor with a spindle shaped incision, and then the blood-rich cystic tumor tissue was found under the scalp. The tumor eroded, damaged the skull, and adhered tightly to the dura mater, but did not invade the brain tissue. After the tumor was completely resected, the dura was repaired with artificial dura mater and repaired the skull with titanium plate bone graft (). The surgically resected tumor tissue was available for histopathological examination after photographing (). Paraffin-embedded hematoxylin and eosin (H&E) stained sections showed unencapsulated, lobular, dermally based collections of sebaceous, and the present of atypical mitoses, necrosis and vascular invasion (). These lobules consisted of atypic pleomorphic cells containing nuclear pleomorphism, nuclear hyperchromatism, mitotic figures, and foamy vacuolization of the cytoplasm (). Immunohistochemical staining () was positive for Ki-67, CK-pan, and epithelial membrane antigen (EMA). After operation, the patient was then treated with radiation. The radiotherapy modality was conventional postoperative electronic radiation therapy, the irradiation range was the operation area, and the radiation dose was 60 Gy/2 Gy/30 f. The patient was followed for 3 years and the results have been favorable. And the patient praised our diagnosis and treatment.
Figure 2

General photo and the histological findings of the tumor. (A) General photo of the pathology after surgery showing the excised scalp, tumor, and part of the skull; (B) paraffin-embedded hematoxylin and eosin stained sections show unencapsulated, lobular, dermally based collections of sebaceous, and the presence of atypical mitoses, necrosis and vascular invasion (H&E staining, ×100); (C) these lobules consisted of atypic pleomorphic cells containing nuclear pleomorphism, nuclear hyperchromatism, mitotic figures, and foamy vacuolization of the cytoplasm (H&E staining, ×400); (D,E,F) immunohistochemical staining was positive for Ki-67 (D, ×400), CK-pan (E, ×400), and EMA (F, ×400). EMA, epithelial membrane antigen.

General photo and the histological findings of the tumor. (A) General photo of the pathology after surgery showing the excised scalp, tumor, and part of the skull; (B) paraffin-embedded hematoxylin and eosin stained sections show unencapsulated, lobular, dermally based collections of sebaceous, and the presence of atypical mitoses, necrosis and vascular invasion (H&E staining, ×100); (C) these lobules consisted of atypic pleomorphic cells containing nuclear pleomorphism, nuclear hyperchromatism, mitotic figures, and foamy vacuolization of the cytoplasm (H&E staining, ×400); (D,E,F) immunohistochemical staining was positive for Ki-67 (D, ×400), CK-pan (E, ×400), and EMA (F, ×400). EMA, epithelial membrane antigen. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Helsinki Declaration (as revised in 2013). Written informed consent was obtained from the patient.

Discussion

The MEDLINE database was searched for articles related to aggressive SC of the scalp published from 1945 to 2020. A total of five publications reporting on five patients were retrieved. The clinical profiles are summarized in .
Table 1

The clinical profiles of aggressive SC of the scalp

No.Author (year)Age/sexSymptom durationSize (cm)InvasionMetastasisTreatmentMTSRecurrenceFollow-upOutcome
1De Leo et al. (2006)42/F1 month4.5Brain+Surgery, chemotherapy++11 monthsDeath
2Bhavarajua et al. (2007)29/F2 yearsNot availableDura mater+Surgery, radiotherapy, chemotherapy+15 monthsDeath
3Scuderi et al. (2009)79/FNot availableNot availableBrain+Surgery+Not availableDeath
4Greco et al. (2010)65/F12 years8×10SkullSurgery+Not availableFavorable
5Hadravsky et al. (2016)56/MNot available4×4.5BrainSurgery, radiotherapy++4 yearsDeath
6Present case61/F2 months7.5×4Dura materSurgery, radiotherapy3 yearsFavorable

+, positive; −, negative. SC, sebaceous carcinoma; F, female; M, male; MTS, Muir-Torre syndrome.

+, positive; −, negative. SC, sebaceous carcinoma; F, female; M, male; MTS, Muir-Torre syndrome. Up to 75% of all SC presents as a periocular tumor arising from the ocular adnexa (10). Aggressive SC of the scalp is extremely rare. A total of five cases of locally aggressive SC of scalp were found in the literature, of which three were aggressive to the brain, one invaded the dura mater, one invaded the skull, and three distantly metastasized to the lymph nodes or viscera. The present case invaded the dura mater and did not metastasize. Multiple studies have identified a female predominance among patients diagnosed with SC (11,12). Including this case, a total of six patients are reported, of whom five were females, accounting for 83.3%, and the average age was 55 years old, which was consistent with the characteristics of previous studies. Extraocular SC commonly presents as a painless papule, or cystic nodule, which grows rapidly (13). Regardless of the duration of the symptoms, all the patients retrieved had the characteristics of rapid enlargement in lesions. The importance of a thorough physical examination cannot be emphasized enough, and early detection is critical to provide patients with the best chance for a favorable outcome (14). Extraocular SC can occur sporadically or in the setting of MTS (4). Of the five retrieved cases, two were related to MTS and both had poor prognosis, but our current case did not. Therefore, it is import to acquire the patients’ medical history about neoplasm. In addition, imaging inspection appears to be crucial for aggressive SC of the scalp. CT may reveal skull destruction, and MRI can delineate intracranial soft tissue involvement by tumor. Biopsy of tumor is essential for diagnosis. Sebaceous tumors are separated into three major categories: sebaceous adenoma, basal cell carcinoma with sebaceous differentiation, and SC (13). Four histologic patterns of SC are commonly recognized: lobular, comedocarcinoma, papillary, and mixed. Examination of routine H&E paraffin embedded permanent sections demonstrates lobular architecture, high mitotic activity, nuclear pleomorphism, and foamy vacuolization of the cytoplasm (12,15). Lipids present in the cytoplasm of the cells result in their characteristic “foamy”, which stain positive with oil red O and Sudan black in fresh-frozen samples (12). Immunohistochemistry has largely replaced lipid stains such as oil red O, of which the sensitivity decreases after formalin fixation, in the diagnosis of SC (15). Extraocular SC cells stain with EMA, cytokeratin (CK), Ber-EP4, and androgen receptor (13). Compared to benign counterparts, extraocular SC expresses increased p53 and Ki-67 levels (13). In the current case, Ki-67, CK-pan, and EMA are highly expressed, which is consistent with the typical immunohistochemical features of SC. The main differential diagnoses are clear cell hidradenocarcinoma, clear cell melanoma, squamous cell carcinoma composed of clear cells, metastatic renal cell carcinoma, and metastatic prostate carcinoma. Mohs micrographic surgery (MMS) with lower local recurrence rates is the best initial treatment modality for SC (12), especially those with lesions in cosmetically sensitive areas. However, aggressive SC of the scalp has very poor prognosis with 83.3% recurrence rate. Therefore, it is recommended that an enlarged resection be used for the intracranial invasive tumor and then repair of the dura mater or skull in I stage. The extensive scalp defects can be reconstructed using large local scalp flap transposition (16,17). Wide resection with craniectomy and reconstruction with microvascular free tissue transfer provides safe and reliable treatment of recalcitrant invasive scalp skin cancers (18). The role of radiation therapy and systemic chemotherapy after surgery is not clear in the extraocular SC, which are only suggested for patients who are poor surgical candidates or those with recurrent or metastatic disease (12,13,19). Electrochemotherapy has shown to be an interesting tool for treatment of metastatic extraocular SC (20). The patient was treated with external radiation to prevent recurrence and was followed for 3 years with favorable results.

Conclusions

In conclusion, an extremely rare case of aggressive SC on the scalp is reported here. It is necessary to be aware of these rare examples which showed unexpectedly clinical behaviors. Early precise diagnosis and improved radical treatment remain an essential step against aggressive cutaneous malignancy. Patients with aggressive SC of the scalp should be followed up closely to assess recurrence and distant metastasis.
  20 in total

1.  Sebaceous cell carcinoma of scalp - a rare presentation.

Authors:  Venkata Murali Krishna Bhavarajua; S Ejaz Shamim; V R Naik; Shamsol Shaari
Journal:  Malays J Med Sci       Date:  2007-01

2.  Extraocular sebaceous carcinoma in Muirr Torre Syndrome with unfavorable prognosis.

Authors:  A De Leo; D Innocenzi; M G Onesti; C Potenza; M Toscani; N Scuderi
Journal:  Cancer Chemother Pharmacol       Date:  2006-05-13       Impact factor: 3.333

Review 3.  Rare malignant tumors of the scalp: a report of four cases, their treatment and a review of the literature.

Authors:  M Greco; T Vitagliano; M A Fiorillo; M Atzeni; A Corona; D Ribuffo
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-11       Impact factor: 3.507

Review 4.  Sebaceous carcinoma: review of the literature.

Authors:  Rachel L Kyllo; Kimberly L Brady; Eva A Hurst
Journal:  Dermatol Surg       Date:  2015-01       Impact factor: 3.398

Review 5.  Sebaceous Carcinoma: A Review of the Scientific Literature.

Authors:  Thomas Knackstedt; Faramarz H Samie
Journal:  Curr Treat Options Oncol       Date:  2017-08

6.  Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data.

Authors:  N A Rao; A A Hidayat; I W McLean; L E Zimmerman
Journal:  Hum Pathol       Date:  1982-02       Impact factor: 3.466

7.  Custom surgical management of invasive malignant tumors of the scalp.

Authors:  Pauline Marijon; Chloé Bertolus; Jean-Philippe Foy; Guillaume Marechal; Jean-Baptiste Caruhel; Mourad Benassarou; Alexandre Carpentier; Vincent Degos; Aymeric Amelot; Bertrand Mathon
Journal:  Acta Neurochir (Wien)       Date:  2020-08-14       Impact factor: 2.216

8.  Sebaceous carcinoma of scalp with proliferating trichilemmal cyst.

Authors:  Siddhi Chikhalkar; Gaurav Garg; Rameshwar Gutte; Uday Khopkar
Journal:  Indian Dermatol Online J       Date:  2012-05

9.  Target splitting non-coplanar RapidArc radiation therapy for a diffuse sebaceous carcinoma of the scalp: a novel delivery technique.

Authors:  Jiang Hu; WeiWei Xiao; ZhiChun He; DeHua Kang; Along Chen; ZhenYu Qi
Journal:  Radiat Oncol       Date:  2014-09-16       Impact factor: 3.481

10.  Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality.

Authors:  Simone Ribero; Eugenio Sportoletti Baduel; Matteo Brizio; Franco Picciotto; Emi Dika; Maria Teresa Fierro; Giuseppe Macripò; Pietro Quaglino
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.